Xlife Sciences AG (XSWX:XLS) ROCE % : 6.36% (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Xlife Sciences AG ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Xlife Sciences AG's annualized ROCE % for the quarter that ended in Dec. 2023 was 6.36%.

Xlife Sciences AG ROCE % Historical Data

The historical data trend for Xlife Sciences AG's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xlife Sciences AG ROCE % Chart

Xlife Sciences AG Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

1.08

12.72

16.26

0.98

0.99

Xlife Sciences AG Semi-Annual Data
	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROCE %	Get a 7-Day Free Trial					34.11	-5.07	6.99	-4.44	6.36

Xlife Sciences AG ROCE % Calculation

Xlife Sciences AG's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	4.919	/	( ( (490.23 - 1.93)	+	(511.994 - 5.832) )	/ 2 )
	=	4.919	/	( (488.3	+	506.162)	/ 2 )
	=	4.919	/	497.231
	=	0.99 %

Xlife Sciences AG's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	31.22	/	( ( (477.941 - 1.917)	+	(511.994 - 5.832) )	/ 2 )
	=	31.22	/	( ( 476.024	+	506.162 )	/ 2 )
	=	31.22	/	491.093
	=	6.36 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

Xlife Sciences AG (XSWX:XLS) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Xlife Sciences AG ROCE % Related Terms

Thank you for viewing the detailed overview of Xlife Sciences AG's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Xlife Sciences AG (XSWX:XLS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xlife Sciences AG (XSWX:XLS) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

XLSz:UK

Address

Talacker 35, Zürich, CHE, 8001

Website

https://www.xlifesciences.ch

Xlife Sciences AG is a Swiss company with a focus on performance technologies in life sciences. The company allows its investors a very early and direct Entry into the further development of innovative and future-oriented technologies.

Xlife Sciences AG (XSWX:XLS) Headlines

No Headlines